XML 92 R13.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Goodwill and Intangible Assets Notes | 12 Months Ended
--- | ---
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company's estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date). The following table presents the changes in the carrying amount of goodwill for the periods indicated:
| Years Ended December 31,
| 2019 |  | 2018
| (in thousands)
Beginning balance | $ | 238,330 |  |  | $ | 237,992 |
Adjustments | — |  |  | 338 |
Ending balance | $ | 238,330 |  |  | $ | 238,330 |
The Company performs an annual goodwill impairment assessment on October 31st each year, using a two-step quantitative assessment. Step one is the identification of potential impairment. This involves comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds the carrying amount, the goodwill of the reporting unit is considered not impaired and the second step of the impairment test is unnecessary. If the carrying amount of a reporting unit exceeds its fair value, the second step of the impairment test is performed to measure the amount of impairment loss, if any. The Company determined there were no indications of impairment associated with goodwill. As a result, no goodwill impairment was recognized as of October 31, 2019. In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. As of December 31, 2019, there were no indications of impairment of the Company’s goodwill balances. Acquired Intangibles Finite-lived Intangible Assets The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized:
|  |  | December 31, 2019 |  | December 31, 2018
| Weighted Average Useful Life (in Years) |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Value |  | Accumulated Amortization |  | Net Carrying Amount
|  |  | (in thousands)
Licensed technology | 3.7 |  | $ | 2,156 |  |  | $ | (1,583 | ) |  | $ | 573 |  |  | $ | 2,070 |  |  | $ | (1,130 | ) |  | $ | 940 |
Developed technology | 6.9 |  | 243,361 |  |  | (108,522 | ) |  | 134,839 |  |  | 238,961 |  |  | (74,630 | ) |  | 164,331 |
Trademarks and trade names | 6.1 |  | 13,800 |  |  | (6,511 | ) |  | 7,289 |  |  | 13,800 |  |  | (4,252 | ) |  | 9,548 |
Customer relationships | 4.6 |  | 121,100 |  |  | (75,847 | ) |  | 45,253 |  |  | 121,100 |  |  | (55,647 | ) |  | 65,453 |
Non-compete covenants | 3.0 |  | 1,100 |  |  | (1,083 | ) |  | 17 |  |  | 1,100 |  |  | (872 | ) |  | 228 |
| 6.1 |  | $ | 381,517 |  |  | $ | (193,546 | ) |  | $ | 187,971 |  |  | $ | 377,031 |  |  | $ | (136,531 | ) |  | $ | 240,500 |
The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
|  | Years Ended December 31,
|  | 2019 |  | 2018 |  | 2017
Cost of net revenue |  | $ | 33,932 |  |  | $ | 35,821 |  |  | $ | 25,316 |
Research and development |  | 48 |  |  | 150 |  |  | 551 |
Selling, general and administrative |  | 23,035 |  |  | 31,976 |  |  | 28,827 |
|  | $ | 57,015 |  |  | $ | 67,947 |  |  | $ | 54,694 |
Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology. The following table sets forth activity during the years ended December 31, 2019 and 2018 related to finite-lived intangible assets:
| Years Ended December 31,
| 2019 |  | 2018
| (in thousands)
Beginning balance | $ | 240,500 |  |  | $ | 310,645 |
Other additions | 86 |  |  | — |
Transfers to developed technology from IPR&D | 4,400 |  |  | — |
Amortization | (57,015 | ) |  | (67,947 | )
Impairment losses | — |  |  | (2,198 | )
Ending balance | $ | 187,971 |  |  | $ | 240,500 |
The Company regularly reviews the carrying amounts of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During the years ended December 31, 2019 and 2017, no impairment losses related to finite-lived intangible assets were recognized. Impairment loss related to finite-lived intangible assets for the year ended December 31, 2018 was $2.2 million and related to acquired developed technology. The following table presents future amortization of the Company’s finite-lived intangible assets at December 31, 2019:
| Amortization (in thousands)
2020 | $ | 56,610 |
2021 | 55,828 |
2022 | 38,298 |
2023 | 26,075 |
2024 | 10,098 |
Thereafter | 1,062 |
Total | $ | 187,971 |
Indefinite-lived Intangible Assets Indefinite-lived intangible assets consist entirely of acquired in-process research and development technology, or IPR&D. The following table sets forth the Company’s activities related to the indefinite-lived intangible assets:
| Years Ended December 31,
| 2019 |  | 2018
| (in thousands)
Beginning balance | $ | 4,400 |  |  | $ | 4,400 |
Transfers to developed technology from IPR&D | (4,400 | ) |  | — |
Ending balance | $ | — |  |  | $ | 4,400 |
The Company performs its annual assessment of indefinite-lived intangible assets on October 31 each year or more frequently if events or changes in circumstances indicate that the asset might be impaired utilizing a qualitative test as a precursor to the quantitative test comparing the fair value of the assets with their carrying amount. Based on the qualitative test, if it is more likely than not that indicators of impairment exists, the Company proceeds to perform a quantitative analysis. Based on the Company’s assessment as of October 31, 2019, no indicators of impairment were identified. In the years ended December 31, 2019 and 2018, no IPR&D impairment losses were recorded. In the year ended December 31, 2017, the Company recognized impairment losses of $2.0 million related to the Company's abandonment of a single IPR&D project.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration